Positive Discipline in Parent Training

February 16, 2024 updated by: Hatice Dayilar Candan, Ege University

The Effectiveness of a Positive Discipline Program Applied To The Parents of Preschool Children: A Randomized Controlled Study

The aim of this study was to examine the effectiveness of a Positive Discipline Program applied to the parents of preschool children. Accordingly, the tertiary aims of this study included determining the effects of a positive discipline program on the child upbringing attitudes of parents with preschool children, their perceptions regarding each other's child upbringing attitudes, and the communication between preschool children and their parents.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This randomized controlled experimental study included pretest, posttest, and monitoring test applications with an intervention group, an active control group, and a no-contact control group. The study was conducted between May 2020 and June 2022. The universe of the study consisted of 653 parents with preschool (ages 3-6) children registered to the Izmir Bornova Şükrü Ergil Family Health Center No:9. Sample size was calculated using power analysis and assigned randomly to the intervention, active control, and no-contact control groups in groups of 24 (n=72). The intervention group was provided with 8 weekly sessions of a 90 minutes positive discipline program while the active control group was provided with 8 weekly 90 minute sessions of free interaction. No intervention was performed with the no-contact control group. Data collection was performed using a Personal Information Form, Parental Attitude Scale (PAS), Assessment of Parenting Attitudes of Couples Scale (APACS) and the Parent Child Communication Scale (PCCS).

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
72

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • İzmir, Turkey
        • Ege University, TAEK

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Registered at Şükrü Ergil Family Health Center No. 9 in Bornova,
  • Agreeing to participate in the research,
  • Having children between the ages of 3-6,
  • Parents have not participated in any parent education program before,
  • Having the cognitive ability to receive education,
  • Able to read and write,
  • Having no problems in hearing, seeing and understanding,
  • Will be able to participate in at least 7 sessions of the positive discipline program and active control group,
  • Capable of using an online program (because it is made online).

Exclusion Criteria:

  • Failure to attend at most one of the positive training program and active control group sessions,
  • Parent's request to withdraw at any stage of the trial.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Intervention group (positive discipline program)
The intervention group was provided with 8 weekly sessions of a 90 minutes positive discipline program.
Behavioral: Positive discipline program
The intervention group was provided with 8 weekly sessions of a 90 minutes positive discipline program
Active Comparator: Active control group (free interaction)
while the active control group was provided with 8 weekly 90 minute sessions of free interaction.
Behavioral: active control group
free interaction group consisting of topics determined by the families.
No Intervention: No-contact group
No intervention was performed with the no-contact control group.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
improvement in parenting attitudes
Time Frame: 8 weeks later
Parental Attitude Scale (PAS) was used that scale consists of three sub-dimension. The 38-item scale has three sub-dimensions: "13 items Democratic Attitude", "10 items Oppressive and Authoritarian Attitude", and "12 items Overprotective Attitude". A high score in each dimension means that the attitude characteristic related to that sub-dimension is dominant. It is expected that this study will change in oppressive and authoritarian, overprotective and democratic parenting attitude.
8 weeks later
improvement in Parenting Attitudes of Couples
Time Frame: 8 weeks later
Assessment of Parenting Attitudes of Couples Scale (APACS) was used that scale consist of four sub-dimension. The scale, which consists of 50 items in total, has four sub-dimensions: "15 items Democratic Attitude", "14 items Oppressive and Authoritarian Attitude", "10 items Overprotective Attitude" and "11 items Permissive Attitude". Higher scores on the APACS indicate that the spouses' child rearing attitudes in the relevant sub-dimension are more dominant by observing the other parent. It is expected that this study will change in these parenting attitude.
8 weeks later
improvement a parent's relationship with their child
Time Frame: 3 months later
Parent Child Communication Scale (PCCS) was used. The parent version of the PCCS involved a 20-item measure that also consisted of a five-point scale ranging from 'almost never' to 'almost always'. This PCCS parent version is composed of four sub-scales: parent communication, parent restricted topics, child/empathy listening, and child emotional expression.I It is understood that the higher the score obtained from the scale, the higher the level of communication of the parent with his/her child. It is expected that this study will change in parent's relationship with their child.
3 months later

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Ege University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Chair: Aysun Eksioglu, PhD. Dr., TAEK

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
May 1, 2021

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
January 1, 2022

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
September 15, 2022

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
May 3, 2022

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 10, 2022

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
May 16, 2022

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
February 20, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 16, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
February 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • Ege HDCandan

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

I finished my thesis and published it in Journal of Pediatric Nusing. I can share my published article.

IPD Sharing Time Frame

starting starting 6 months after publication

IPD Sharing Access Criteria

psychiatric nurse

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parenting

Clinical Trials on Positive discipline program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings